4//SEC Filing
GV 2016 GP, L.L.C. 4
Accession 0000899243-18-007990
CIK 0001724521other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 5:30 PM ET
Size
24.4 KB
Accession
0000899243-18-007990
Insider Transaction Report
Form 4
GV 2016 GP, L.L.C.
10% Owner
Transactions
- Conversion
Series B Convertible Preferred Stock
2018-03-19−3,125,312→ 0 total(indirect: By GV 2016, L.P.)→ Common Stock (3,125,312 underlying) - Conversion
Common Stock
2018-03-19+3,125,312→ 3,125,312 total(indirect: By GV 2016, L.P.)
GV 2016, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2018-03-19+3,125,312→ 3,125,312 total(indirect: By GV 2016, L.P.) - Conversion
Series B Convertible Preferred Stock
2018-03-19−3,125,312→ 0 total(indirect: By GV 2016, L.P.)→ Common Stock (3,125,312 underlying)
Alphabet Inc.
10% Owner
Transactions
- Conversion
Common Stock
2018-03-19+3,125,312→ 3,125,312 total(indirect: By GV 2016, L.P.) - Conversion
Series B Convertible Preferred Stock
2018-03-19−3,125,312→ 0 total(indirect: By GV 2016, L.P.)→ Common Stock (3,125,312 underlying)
GV 2016 GP, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2018-03-19+3,125,312→ 3,125,312 total(indirect: By GV 2016, L.P.) - Conversion
Series B Convertible Preferred Stock
2018-03-19−3,125,312→ 0 total(indirect: By GV 2016, L.P.)→ Common Stock (3,125,312 underlying)
Footnotes (3)
- [F1]The total represents shares received upon conversion of shares of Series B Convertible Preferred Stock.
- [F2]The reported security is directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2016 GP, L.P., GV 2016 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- [F3]The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001722201
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 5:30 PM ET
- Size
- 24.4 KB